© 2022 BioMarin. All rights reserved.

Financial Statements

NASDAQBMRN
All numbers in thousands USD
Period Ending
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Total Revenue
1,846,275
1,860,461
--
1,491,212
Cost of Revenue
470,515
524,272
--
315,264
Gross Profit
1,375,760
1,336,189
--
1,175,948
Operating Expenses
Research Development
628,793
628,116
--
696,328
Selling General and Administrative
759,375
737,700
--
604,353
Non Recurring
--
--
--
--
Others
69,933
62,200
--
48,791
Total Operating Expenses
1,458,101
1,428,016
--
1,349,472
Operating Income or Loss
(82,341)
(91,827)
--
(173,524)
Income from Continuing Operations
Total Other Income/Expenses Net
11,846
62,137
--
51,652
Earnings Before Interest And Taxes
(60,013)
(13,013)
--
(102,651)
Interest Expense
15,337
29,309
--
40,054
Income Before Tax
(75,350)
(42,322)
--
(142,705)
Income Tax Expense
(11,270)
(901,422)
--
(65,494)
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(64,080)
859,100
--
(77,211)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
--
0
Net Income
(64,080)
859,100
--
(77,211)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(64,080)
859,100
--
(77,211)